Interferon-β and interferon-γ are weak inhibitors of ebola virus in cell-based assays

Julie Dyall; Brit J. Hart; Elena Postnikova; Yu Cong; Huanying Zhou; Dawn M. Gerhardt; Denise Freeburger; Julia Michelotti; Anna N. Honko; Lisa Evans DeWald; Richard S. Bennett; Gene G. Olinger; Peter B. Jahrling; Lisa E. Hensley

doi:10.1093/infdis/jix134

Interferon-β and interferon-γ are weak inhibitors of ebola virus in cell-based assays

Julie Dyall, Brit J. Hart, Elena Postnikova, Yu Cong, Huanying Zhou, Dawn M. Gerhardt, Denise Freeburger, Julia Michelotti, Anna N. Honko, Lisa Evans DeWald, Richard S. Bennett, Gene G. Olinger, Peter B. Jahrling, Lisa E. Hensley

Research output: Contribution to journal › Article › peer-review

Abstract

Previous studies have demonstrated little efficacy of interferons (IFNs) in animal models of Ebola virus disease. However, these studies were limited to a small number of type I IFNs and, during the most recent outbreak of Ebola virus, questions regarding the suitability of the animal models to evaluate IFNs were raised. To address the potential that anti-Ebola virus activity was overlooked, type I and type II IFNs (α-2a, α-2b, -β, -γ, and -universal) were tested in a variety of cell types (Vero E6, Huh 7 cells, and human macrophages). IFNs are weak inhibitors of Ebola virus Makona in these cell lines.

Original language	English (US)
Pages (from-to)	1416-1420
Number of pages	5
Journal	Journal of Infectious Diseases
Volume	215
Issue number	9
DOIs	https://doi.org/10.1093/infdis/jix134
State	Published - May 1 2017
Externally published	Yes

Keywords

antiviral
Ebola virus
interferon

ASJC Scopus subject areas

Immunology and Allergy
Infectious Diseases

Access to Document

10.1093/infdis/jix134

Cite this

Dyall, J., Hart, B. J., Postnikova, E., Cong, Y., Zhou, H., Gerhardt, D. M., Freeburger, D., Michelotti, J., Honko, A. N., DeWald, L. E., Bennett, R. S., Olinger, G. G., Jahrling, P. B., & Hensley, L. E. (2017). Interferon-β and interferon-γ are weak inhibitors of ebola virus in cell-based assays. Journal of Infectious Diseases, 215(9), 1416-1420. https://doi.org/10.1093/infdis/jix134

Dyall, J, Hart, BJ, Postnikova, E, Cong, Y, Zhou, H, Gerhardt, DM, Freeburger, D, Michelotti, J, Honko, AN, DeWald, LE, Bennett, RS, Olinger, GG, Jahrling, PB & Hensley, LE 2017, 'Interferon-β and interferon-γ are weak inhibitors of ebola virus in cell-based assays', Journal of Infectious Diseases, vol. 215, no. 9, pp. 1416-1420. https://doi.org/10.1093/infdis/jix134

@article{9d25ab89e1a84eb0a427f347cbba832d,

title = "Interferon-β and interferon-γ are weak inhibitors of ebola virus in cell-based assays",

abstract = "Previous studies have demonstrated little efficacy of interferons (IFNs) in animal models of Ebola virus disease. However, these studies were limited to a small number of type I IFNs and, during the most recent outbreak of Ebola virus, questions regarding the suitability of the animal models to evaluate IFNs were raised. To address the potential that anti-Ebola virus activity was overlooked, type I and type II IFNs (α-2a, α-2b, -β, -γ, and -universal) were tested in a variety of cell types (Vero E6, Huh 7 cells, and human macrophages). IFNs are weak inhibitors of Ebola virus Makona in these cell lines.",

keywords = "antiviral, Ebola virus, interferon",

author = "Julie Dyall and Hart, {Brit J.} and Elena Postnikova and Yu Cong and Huanying Zhou and Gerhardt, {Dawn M.} and Denise Freeburger and Julia Michelotti and Honko, {Anna N.} and DeWald, {Lisa Evans} and Bennett, {Richard S.} and Olinger, {Gene G.} and Jahrling, {Peter B.} and Hensley, {Lisa E.}",

note = "Publisher Copyright: {\textcopyright} The Author 2017. Published by Oxford University Press for the Infectious Diseases Society.",

year = "2017",

month = may,

day = "1",

doi = "10.1093/infdis/jix134",

language = "English (US)",

volume = "215",

pages = "1416--1420",

journal = "Journal of Infectious Diseases",

issn = "0022-1899",

publisher = "Oxford University Press",

number = "9",

}

TY - JOUR

T1 - Interferon-β and interferon-γ are weak inhibitors of ebola virus in cell-based assays

AU - Dyall, Julie

AU - Hart, Brit J.

AU - Postnikova, Elena

AU - Cong, Yu

AU - Zhou, Huanying

AU - Gerhardt, Dawn M.

AU - Freeburger, Denise

AU - Michelotti, Julia

AU - Honko, Anna N.

AU - DeWald, Lisa Evans

AU - Bennett, Richard S.

AU - Olinger, Gene G.

AU - Jahrling, Peter B.

AU - Hensley, Lisa E.

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Previous studies have demonstrated little efficacy of interferons (IFNs) in animal models of Ebola virus disease. However, these studies were limited to a small number of type I IFNs and, during the most recent outbreak of Ebola virus, questions regarding the suitability of the animal models to evaluate IFNs were raised. To address the potential that anti-Ebola virus activity was overlooked, type I and type II IFNs (α-2a, α-2b, -β, -γ, and -universal) were tested in a variety of cell types (Vero E6, Huh 7 cells, and human macrophages). IFNs are weak inhibitors of Ebola virus Makona in these cell lines.

AB - Previous studies have demonstrated little efficacy of interferons (IFNs) in animal models of Ebola virus disease. However, these studies were limited to a small number of type I IFNs and, during the most recent outbreak of Ebola virus, questions regarding the suitability of the animal models to evaluate IFNs were raised. To address the potential that anti-Ebola virus activity was overlooked, type I and type II IFNs (α-2a, α-2b, -β, -γ, and -universal) were tested in a variety of cell types (Vero E6, Huh 7 cells, and human macrophages). IFNs are weak inhibitors of Ebola virus Makona in these cell lines.

KW - antiviral

KW - Ebola virus

KW - interferon

UR - http://www.scopus.com/inward/record.url?scp=85021884460&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021884460&partnerID=8YFLogxK

U2 - 10.1093/infdis/jix134

DO - 10.1093/infdis/jix134

M3 - Article

C2 - 28368541

AN - SCOPUS:85021884460

SN - 0022-1899

VL - 215

SP - 1416

EP - 1420

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

IS - 9

ER -

Interferon-β and interferon-γ are weak inhibitors of ebola virus in cell-based assays

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this